CC2019: Gastric and Gastroesophageal Junction Cancer: Latest Advances (C)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Cancer. Learn more about ACS Accreditation/Verification Requirements.
Gastric and gastroesophageal cancers are a global problem and there have been advances in treatment in the past few years. The topics to be addressed in this session will include the methods of evaluation and imaging, the proper use of neoadjuvant therapy, and controversies in the extent of resection and lymphadenectomy.
Moderator: Alexander A. Parikh, MD, MPH, FACS, Greenville, NC
Co-Moderator: Wayne L. Hofstetter, MD, FACS, Houston, TX
Alexander A. Parikh, MD, MPH, FACS, Greenville, NC
Wayne L. Hofstetter, MD, FACS, Houston, TX
Preoperative Chemoradiation Should Be Recommended for All Proximal Gastric and Esophagogastric (EG) Junction Tumors
Michael O. Meyers, MD, FACS, Chapel Hill, NC
Chemoradiation Is Not Needed for Proximal Gastric and EG Junction Tumors
Waddah B. Al-Refaie, MD, FACS, Washington, DC
Thoracic vs. Abdominal Approach for Proximal Gastric and EG Junction Tumors
Naruhiko Ikoma, MD, Houston, TX
Sponsored by the Advisory Council for General Surgery and the Commission on Cancer
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
For questions about the course, please contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures).
Faculty and Disclosures
Alexander A. Parikh MD, MPH, FACS - Nothing to Disclose
Michael O. Meyers MD, FACS - Nothing to Disclose
Naruhiko Ikoma MD MS - Nothing to Disclose
Waddah B. Al-Refaie MD, FACS - Nothing to Disclose
Wayne L. Hofstetter, MD, FACS - Ethicon/Neuwave: Research support
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure
David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure
Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit